Clinical Trials Directory

Trials / Completed

CompletedNCT02280382

An Intervention to Improve Prolapse Using Femmeze® (v1)

An Intervention to Improve the Management of Posterior Vaginal Compartment Prolapse Using Femmeze®: a Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Royal Cornwall Hospitals Trust · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The main purpose of the feasibility study is to identify the patient experience of Femmeze® which is a device aimed at improving posterior vaginal compartment prolapse (rectocele) for women with obstructive defaecation. The investigators want to investigate implementation and preliminary effectiveness of the device. The method of investigation will be a pre-post intervention design, which involves asking 30 women to use Femmeze® over a period of 8 weeks. This is an academic study on a labelled indication (http://www.nres.nhs.uk/search/?q=medical+devices).

Detailed description

Aim Evaluate the feasibility of the Femmeze® device to improve management of posterior vaginal compartment prolapse addressing implementation of the intervention and preliminary effectiveness. Objectives * demonstrate effectiveness of the device (comfort, ease of use, empty the rectum of stool more easily than their current approach and quality of life) * identify which stage of prolapse the device would be most suitable * identify any changes to the device or instructions for use (needs adjustment to its design in terms of length/width) The study will use a pre-post intervention design with the aim of evaluating the feasibility of the intervention (using the device); and identifying any implementation issues and preliminary effectiveness. The participants will be followed prospectively to compare the device against their own usual care. Usual care in this context will be using their fingers to help empty their rectum of stool. Participants will be invited to complete a semi-structured interview to understand their lived experience. A Patient and Public Involvement Group has contributed to improving the study methods.

Conditions

Interventions

TypeNameDescription
DEVICEFemmeze®Femmeze will be used by women in the intervention group for 8 weeks These women will be measuring against their usual care in a linear design; measurement will include validated questionnaires

Timeline

Start date
2015-10-01
Primary completion
2018-12-01
Completion
2019-03-01
First posted
2014-10-31
Last updated
2019-03-29

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02280382. Inclusion in this directory is not an endorsement.